Use of tunneled pleural catheters in Malignant mesothelioma

Journal of Bronchology

Volumn 12, Issue 4, 2005, Pages 203-206

  Tremblay, Alain ^a,b,d   Patel, Milan ^c   Michaud, Gaëtane ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Southern Alberta Cancer Research Institute   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Departments of Medicine and Community Health Sciences   (Canada)

Author keywords

Cancer; Chest tube; Mesothelioma; Pleural effusion; Pleurodesis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CATHETER; CATHETERIZATION; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DYSPNEA; FEMALE; HUMAN; MALE; MALIGNANT MESOTHELIOMA; PLEURA EFFUSION; PLEURODESIS; PRIORITY JOURNAL; REOPERATION; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 28044438369     PISSN: 10708030     EISSN: 15367959     Source Type: Journal    
DOI: 10.1097/01.laboratory.0000188644.81416.3c     Document Type: Article

References (22)

1. Pistolesi M, Rusthoven J. Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies. Chest. 2004;126:1318-1329.
2. Sterman DH, Kaiser LR, Albelda SM. Advances in the treatment of malignant pleural mesothelioma. Chest. 1999;116:504-520.
3. Viallat JR, Rey F, Astoul P, et al. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest. 1996;110:1387-1393.
4. Musani AI, Haas AR, Seijo L, et al. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration (Herrlisheim). 2004;71:559-566.
5. Pollak JSM. Treatment of malignant pleural effusions with tunneled long-term drainage catheters. J Vasc Interv Radiol. 2001;12:201-208.
6. Putnam JB Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg. 2000;69:369-375.
7. Putnam JB Jr, Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999;86:1992-1999.
8. Seijo L, Sterman D. Treatment of mesotheliomatous pleural effusion: experimental therapy versus thoracoscopic talc poudrage? Pro: experimental therapy. Journal of Bronchology. 2001;8:47-53.
9. Tremblay A, Michaud G. Single center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2005 (In press).
10. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636-2644.
11. Merritt N, Blewett CJ, Miller JD, et al. Survival after conservative (palliative) management of pleural malignant mesothelioma. J Surg Oncol. 2001;78:171-174.
12. Brancatisano RP, Joseph MG, McCaughan BC. Pleurectomy for mesothelioma. Med J Aust. 1991;154:455-457, 460.
13. Canto A. Videothoracoscopy in the diagnosis and treatment of malignant pleural mesothelioma with associated pleural effusions. Thorac Cardiovasc Surg. 1997;45:16.
14. Colaut F, Toniolo L, Vicario G, et al. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma. Chir Ital. 2004;56:781-786.
15. Grossebner MW, Arifi AA, Goddard M, et al. Mesothelioma - VATS biopsy and lung mobilization improves diagnosis and palliation. Eur J Cardiothorac Surg. 1999;16:619-623.
16. Martin-Ucar AE, Edwards JG, Rengajaran A, et al. Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control. Eur J Cardiothorac Surg. 2001;20:1117-1121.
17. Soysal O, Karaoglanoglu N, Demiracan S, et al. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery. Eur J Cardiothorac Surg. 1997;11:210-213.
18. Waller DA, Morritt GN, Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest. 1995;107:1454-1456.
19. Aelony Y. Treatment of mesotheliomatous pleural effusion. Pro: talc poudrage therapy. Journal of Bronchology. 2001;8:34-39.
20. de Campos JRM, Vargas FS, Werebe EC, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest. 2001;119:801-806.
21. Senyigit A, Bayram H, Babayigit C, et al. Comparison of the effectiveness of some pleural sclerosing agents used for control of effusions in malignant pleural mesothelioma: a review of 117 cases. Respiration (Herrlisheim). 2000;67:623-629.
22. Dresler CM, Olak J, Herndon JE, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005;127:909-915.